TTNP News and Press, Titan Pharmaceuticals Inc. From 01/09/24

2024-01-09 12:43:25 ET Gainers: Neximmune NEXI +96% . Sentage Holdings SNTG +58% . Mountain Crest Acquisition Corp IV MCAF +48% . Zoomcar Holdings ZCAR +42% . Cutera CUTR +37% . Adicet Bio ( ACET ) +33% . Solid Biosciences ( SLDB ...

2024-01-08 08:02:08 ET Titan Pharmaceuticals, Inc. (de) (TTNP) announced stock split at a ratio of 1-for-20 on 2024-01-09 ... Full story available on KlickAnalytics.com

2023-12-28 16:30:57 ET More on Titan Pharmaceuticals Financial information for Titan Pharmaceuticals For further details see: Titan Pharmaceuticals to conduct 1-for-20 reverse stock split

SOUTH SAN FRANCISCO, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that its Board of Directors has approved a 1-for-20 reverse stock split of the Company's common stock, which will be eff...

INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...

Titan Pharmaceuticals Inc. (TTNP) is expected to report for Q1 2024

SAN FRANCISCO, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") is pleased to announce the appointments of Dato’ Seow Gim Shen and Brynner Chiam to the Company’s Board of Directors, effective October 12, 2023. Mr. Shen has also ...

2023-09-18 08:10:47 ET More on Titan Pharmaceuticals Financial information for Titan Pharmaceuticals For further details see: Titan Pharmaceuticals reports $9.5M private placement of convertible preferred stock

SAN FRANCISCO, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") announced today that it has entered into a definitive securities purchase agreement (the “Purchase Agreement”) with The Sire Group Ltd. (“Sire Group”...

SAN FRANCISCO, July 27, 2023 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has entered into an Asset Purchase Agreement (the “Agreement”) with Fedson, Inc., a Delaware Corporation (“Fedson”), for the s...